Evotec delivers integrated immunology and inflammation solutions designed to accelerate drug discovery from target validation through to preclinical development. Leveraging advanced in vitro and in vivo models, human-relevant systems, and cutting-edge technologies such as CRISPR and iPSC-based platforms, Evotec enables robust, translational insights into immune-mediated diseases. With deep expertise across diverse target classes and disease indications, the platform supports efficient identification and validation of novel therapeutic approaches, driving precision medicine in autoimmunity and chronic inflammation.